BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Constitutively upregulated BCR-ABL1 fusion tyrosine kinase (TK) activity in chronic myeloid leukemia (CML) initiates complex signaling that dysregulates and transforms hematopoietic stem cells into CML (leukemia) stem cells or LSC.